IOVANCE BIOTHERAPEUTICS INC (IOVA)

US4622601007 - Common Stock

7.65  -0.14 (-1.8%)

After market: 7.65 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to IOVA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 24.24. This target is 216.92% above the current price.
IOVA was analyzed by 21 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IOVA.
In the previous month the buy percentage consensus was at a similar level.
IOVA was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 7.6510.1024.4824.2435.70 - 32.03% 220.00% 216.92% 366.67%
Up and Down Grades
Date Firm Action Rating
2024-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-24 UBS Initiate Buy
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-29 Piper Sandler Downgrade Overweight -> Neutral
2024-06-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-20 JMP Securities Maintains Market Outperform -> Market Outperform
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-14 Piper Sandler Maintains Overweight -> Overweight
2024-03-07 Truist Securities Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 Wells Fargo Maintains Overweight -> Overweight
2024-02-29 Barclays Maintains Overweight -> Overweight
2024-02-29 Goldman Sachs Maintains Buy -> Buy
2024-02-29 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-21 Goldman Sachs Maintains Buy -> Buy
2024-02-20 Chardan Capital Maintains Buy -> Buy
2024-02-20 JMP Securities Maintains Market Outperform -> Market Outperform
2024-02-20 Wells Fargo Maintains Overweight -> Overweight
2024-02-20 Goldman Sachs Maintains Buy -> Buy
2024-02-20 Piper Sandler Maintains Overweight -> Overweight
2023-12-27 Truist Securities Reiterate Buy -> Buy
2023-12-27 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-20 Goldman Sachs Initiate Buy
2023-11-08 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-18 Barclays Maintains Overweight -> Overweight
2023-09-15 Mizuho Reiterate Buy -> Buy